Go to deals
Healthcare

Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S

Chirana T. Injecta, a.s. has announced the acquisition of Vitrex Medical A/S, the Danish disposable medical and laboratory devices manufacturing company developing, producing and selling disposable articles, primarily for blood sample taking and analysis. Financial details have not been disclosed.

Chirana T. Injecta, a.s. is a manufacturer of disposable medical devices (lancets, syringes, needles, cannulas).

Oaklins' team in the Czech Republic advised the buyer in this transaction.

Parties

Talk to the deal team

Vladimír Jaros

Principal
Prague, Czech Republic
Oaklins WOOD & Co.

Michal Staron

Partner
Bratislava, Slovakia
Oaklins WOOD & Co.

Related deals

The Providence Projects has been acquired by UKAT Group
Private Equity | Healthcare

The Providence Projects has been acquired by UKAT Group

Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.

Learn more
St. Claraspital AG has been acquired by University Hospital Basel
Healthcare

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).

Learn more
RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
Private Equity | Healthcare | TMT

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital

RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.

Learn more